ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

In Brief: House Appropriations Committee Gives NCI $725 Million, Smallest Increase Since 1970

June 1, 1975

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986